Dr. Craig Ramirez is the Co-Founder and CEO of Tezcat Biosciences. Prior to founding Tezcat, Dr. Ramirez was a post-doctoral researcher in the Developmental Therapeutics lab at UT Austin Dell Medical School, under the leadership of Dr. Gail Eckhardt. He obtained his PhD in cancer metabolism at NYU School of Medicine under the leadership of Dr. Dafna Bar-Sagi, a world-renowned expert in Ras-driven cancers and macropinocytosis. During this time in the lab, Dr. Ramirez uncovered novel therapeutic targets and mechanisms of action, several of which represent the backbone of Tezcat’s technology. In addition to research, Dr. Ramirez has been engaged in various entrepreneurship and executive programs, including the Texas Medical Center Accelerator for Cancer Therapeutics, Johnson & Johnson’s CEO Development Program, MassBioDrive, and NYU Stern’s Endless Frontier Labs, to further develop the core skill sets and relationships for successful biotech ventures.